Concepedia

Bengt Ohlsson

BO

2

Publications

48

Citations

2

H-Index

2014

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Bengt Ohlsson is an author at AstraZeneca (Sweden) specializing in medicinal chemistry, bioanalysis, and drug discovery.

Top concepts

Publications per year

2014–2020

2

Publications

2

Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein–Protein Interaction

Leifeng Cheng, Daniel Pettersen, Bengt Ohlsson et al. · ACS Medicinal Chemistry Letters · 2014 · 37 citations · Full text

, , +24

Identification of novel GPR81 agonist lead series for target biology evaluation

Öjvind Davidsson, Kristina Nilsson, Jonas Brånalt et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 11 citations · Full text

Rows per page

1–2 of 2